AbbVie Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AbbVie Inc. on March 12, 2021. The filing discloses a temporary suspension of trading under the company's employee benefit plans and related trading restrictions for directors and executive officers.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on administrative changes to employee benefit plans rather than financial performance.
Material Changes
The primary material event is the implementation of a "Blackout Period" for the AbbVie Savings Plan and the AbbVie Puerto Rico Savings Plan. This restriction is necessitated by administrative changes, including:
- A recordkeeper change for the Plans.
- A trustee change for the Savings Plan.
- A custodian change for the PR Savings Plan.
Outlook, Risks, and Unusual Items
Blackout Period Details:
- Expected Start: March 29, 2021, at 3:00 p.m. CT.
- Expected End: The week of April 11, 2021.
- Restrictions: During this period, participants cannot change contribution rates, direct or diversify investments (including AbbVie common stock), or obtain loans, withdrawals, and distributions.
Executive Trading Restrictions: On March 12, 2021, directors and executive officers were notified of trading restrictions on AbbVie common stock and derivatives during the Blackout Period pursuant to Section 306 of the Sarbanes-Oxley Act and Rule 104 of Regulation BTR.
Key Facts for Investor Verification
- Verify the exact start and end dates of the Blackout Period, as the filing provides expected dates subject to change.
- Confirm the impact of the recordkeeper, trustee, and custodian changes on plan administration.
- Note that the filing does not contain updated financial guidance or operational metrics.